Posts Archive

Dec 8, 2020

NCT04398485: Phase 1: A Study of ION251 Administered to Patients With Relapsed/Refractory Myeloma

NCT04398485: Phase 1: A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma A Study of ION251 Administered...